首页 > 最新文献

Anesthesiology Research and Practice最新文献

英文 中文
Low-Dose Ketamine Infusion for Perioperative Pain Management in Patients Undergoing Laparoscopic Gastric Bypass: A Prospective Randomized Controlled Trial. 低剂量氯胺酮输注治疗腹腔镜胃旁路手术患者围手术期疼痛:一项前瞻性随机对照试验。
IF 1.4 Q2 ANESTHESIOLOGY Pub Date : 2021-07-21 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5520517
Mitchell T Seman, Shawn H Malan, Matthew R Buras, Richard J Butterfield, Kristi L Harold, James A Madura, David M Rosenfeld, Andrew W Gorlin

Introduction: Obesity is a common comorbidity seen in the perioperative setting and is associated with many diseases including cardiovascular disease and obstructive sleep apnea. Laparoscopic Roux-en-Y gastric bypass is the gold standard surgical treatment for patients whose weight is refractory to diet and exercise. Caring for these patients perioperatively presents unique challenges to anesthesiologists and is associated with an increased risk of adverse respiratory events. In our study, we hypothesize that a low-dose perioperative ketamine infusion will reduce opioid consumption and improve analgesia when compared to standard therapy.

Methods: This is a single-center, prospective randomized controlled study enrolling 35 patients in total. Patients were randomized equally into the ketamine and control group. Preop, intraop, and postop management regimens were standardized. The ketamine group received a 0.3 mg/kg ideal body weight ketamine bolus after induction followed by a 0.2 mg/kg/hr ketamine infusion continued into the postop setting for up to 24 hours. Data collected included total perioperative opioids used converted to oral morphine equivalents (ME), pain scores, side effects, hospital length of stay, and patient satisfaction captured via postoperative questionnaires.

Results: The use of perioperative opioid consumption was significantly lower in the ketamine group when compared with the control group (179.9 ME versus 248.7 ME, P=0.03). There was no statistically significant difference in pain scores or hospital length of stay postoperatively between the two groups. There were also no reported adverse respiratory events, prolonged sedation, agitation, or other side effects reported in either group. The patient satisfaction questionnaires showed a significant difference with the ketamine group reporting lower maximum pain scores, a decrease in how pain limited activities of daily living once discharged, and increased hospital pain management satisfaction scores.

Conclusions: Perioperative low-dose ketamine infusions significantly reduced opioid consumption in morbidly obese patients undergoing laparoscopic gastric bypass surgery.

肥胖是围手术期常见的合并症,与心血管疾病和阻塞性睡眠呼吸暂停等多种疾病有关。腹腔镜Roux-en-Y胃旁路手术是饮食和运动对体重难以耐受的患者的金标准手术治疗。围手术期护理这些患者对麻醉师提出了独特的挑战,并与不良呼吸事件的风险增加有关。在我们的研究中,我们假设与标准治疗相比,低剂量的围手术期氯胺酮输注可以减少阿片类药物的消耗并改善镇痛。方法:这是一项单中心、前瞻性随机对照研究,共纳入35例患者。患者随机分为氯胺酮组和对照组。术前、术中、术后管理方案标准化。氯胺酮组在诱导后给予0.3 mg/kg理想体重氯胺酮丸,随后0.2 mg/kg/hr氯胺酮输注,持续至停药后24小时。收集的数据包括围手术期使用的阿片类药物转化为口服吗啡当量(ME)、疼痛评分、副作用、住院时间以及通过术后问卷获取的患者满意度。结果:氯胺酮组围手术期阿片类药物使用量明显低于对照组(179.9 ME vs 248.7 ME, P=0.03)。两组患者的疼痛评分和术后住院时间均无统计学差异。两组均无不良呼吸事件、长时间镇静、躁动或其他副作用的报告。患者满意度问卷显示,氯胺酮组报告的最大疼痛评分较低,出院后疼痛限制日常生活活动的程度降低,医院疼痛管理满意度评分较高。结论:围手术期低剂量氯胺酮输注可显著减少接受腹腔镜胃旁路手术的病态肥胖患者的阿片类药物消耗。
{"title":"Low-Dose Ketamine Infusion for Perioperative Pain Management in Patients Undergoing Laparoscopic Gastric Bypass: A Prospective Randomized Controlled Trial.","authors":"Mitchell T Seman,&nbsp;Shawn H Malan,&nbsp;Matthew R Buras,&nbsp;Richard J Butterfield,&nbsp;Kristi L Harold,&nbsp;James A Madura,&nbsp;David M Rosenfeld,&nbsp;Andrew W Gorlin","doi":"10.1155/2021/5520517","DOIUrl":"https://doi.org/10.1155/2021/5520517","url":null,"abstract":"<p><strong>Introduction: </strong>Obesity is a common comorbidity seen in the perioperative setting and is associated with many diseases including cardiovascular disease and obstructive sleep apnea. Laparoscopic Roux-en-Y gastric bypass is the gold standard surgical treatment for patients whose weight is refractory to diet and exercise. Caring for these patients perioperatively presents unique challenges to anesthesiologists and is associated with an increased risk of adverse respiratory events. In our study, we hypothesize that a low-dose perioperative ketamine infusion will reduce opioid consumption and improve analgesia when compared to standard therapy.</p><p><strong>Methods: </strong>This is a single-center, prospective randomized controlled study enrolling 35 patients in total. Patients were randomized equally into the ketamine and control group. Preop, intraop, and postop management regimens were standardized. The ketamine group received a 0.3 mg/kg ideal body weight ketamine bolus after induction followed by a 0.2 mg/kg/hr ketamine infusion continued into the postop setting for up to 24 hours. Data collected included total perioperative opioids used converted to oral morphine equivalents (ME), pain scores, side effects, hospital length of stay, and patient satisfaction captured via postoperative questionnaires.</p><p><strong>Results: </strong>The use of perioperative opioid consumption was significantly lower in the ketamine group when compared with the control group (179.9 ME versus 248.7 ME, <i>P</i>=0.03). There was no statistically significant difference in pain scores or hospital length of stay postoperatively between the two groups. There were also no reported adverse respiratory events, prolonged sedation, agitation, or other side effects reported in either group. The patient satisfaction questionnaires showed a significant difference with the ketamine group reporting lower maximum pain scores, a decrease in how pain limited activities of daily living once discharged, and increased hospital pain management satisfaction scores.</p><p><strong>Conclusions: </strong>Perioperative low-dose ketamine infusions significantly reduced opioid consumption in morbidly obese patients undergoing laparoscopic gastric bypass surgery.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2021 ","pages":"5520517"},"PeriodicalIF":1.4,"publicationDate":"2021-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321702/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39264622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Comparison of Hemodynamic Response following Spinal Anesthesia between Controlled Hypertensive and Normotensive Patients Undergoing Surgery below the Umbilicus: An Observational Prospective Cohort Study. 一项观察性前瞻性队列研究:接受脐下手术的控制高血压和正常血压患者脊髓麻醉后血液动力学反应的比较。
IF 1.4 Q2 ANESTHESIOLOGY Pub Date : 2021-07-13 eCollection Date: 2021-01-01 DOI: 10.1155/2021/8891252
Leake Gebrargs, Bereket Gebremeskel, Bacha Aberra, Assefa Hika, Yusuf Yimer, Misrak Weldeyohannes, Suleiman Jemal, Degena Behrey, Abere Tilahun

Background: Hypotension and bradycardia are the most common complications associated with spinal anesthesia and more common in patients with a history of hypertension. Regular use of antihypertensive medications can prevent these complications. The occurrence of hypotension under spinal anesthesia among controlled hypertensive and normotensive patients with age 40 years and above is still debated. The objective of the study was to compare blood pressure and heart rate changes following spinal anesthesia between controlled hypertensive and normotensive patients undergoing surgery below the umbilicus at Black lion hospital, Addis Ababa, Ethiopia, 2020.

Method: A hospital-based prospective cohort study was conducted. A total of 110 elective patients with controlled hypertension (55) and normotensive (55) patients who underwent surgery with spinal anesthesia at black lion hospital during the study period were included. The sample was selected using a systematic random sampling technique. Continuous data of independent and dependent variables were analyzed using an independent sample t-test for normally distributed and Mann-Whitney U-test for nonnormally distributed between the study groups. Categorical variables between the study groups were analyzed using the chi-square test. Descriptive data were displayed using tables and figures. For continuous and categorical variables, a p value <0.05 was considered statistically significant.

Results: The incidence of hypotension in the controlled hypertension group (23.6%) was higher than the normotensive group (7.3%) with p value of 0.018. The occurrence of bradycardia was seen to be 12.7% in each group with a p value >0.05. There was a statistically significant difference in the mean systolic blood pressure, mean arterial pressure, mean heart rate, and vasopressor consumption at the measurement time interval between controlled hypertension and normotensive groups.

Conclusion: Under spinal anesthesia, patients with controlled hypertension are more likely to develop hypotension than normotensive patients, but on the occurrence of bradycardia, there was no statistically significant difference between the two groups.

背景:低血压和心动过缓是脊髓麻醉最常见的并发症,在有高血压病史的患者中更为常见。定期使用抗高血压药物可以预防这些并发症。40岁及以上的控制高血压和正常血压患者腰麻下低血压的发生仍有争议。该研究的目的是比较2020年埃塞俄比亚亚的斯亚贝巴黑狮子医院接受脐下手术的控制高血压和正常高血压患者在脊髓麻醉后的血压和心率变化。方法:采用以医院为基础的前瞻性队列研究。研究期间在黑狮医院行脊髓麻醉手术的110例选择性高血压患者(55例)和血压正常者(55例)。采用系统随机抽样技术选择样本。自变量和因变量的连续数据在研究组之间采用正态分布的独立样本t检验和非正态分布的Mann-Whitney u检验进行分析。研究组之间的分类变量采用卡方检验进行分析。描述性数据以表格和图形显示。结果:高血压控制组低血压发生率(23.6%)高于正常组(7.3%),p值为0.018。两组的心动过缓发生率均为12.7%,p值>0.05。在测量时间间隔内,高血压控制组和正常血压组的平均收缩压、平均动脉压、平均心率和血管加压药消耗量差异有统计学意义。结论:在脊髓麻醉下,控制高血压的患者发生低血压的可能性高于血压正常的患者,但在发生心动过缓方面,两组间差异无统计学意义。
{"title":"Comparison of Hemodynamic Response following Spinal Anesthesia between Controlled Hypertensive and Normotensive Patients Undergoing Surgery below the Umbilicus: An Observational Prospective Cohort Study.","authors":"Leake Gebrargs,&nbsp;Bereket Gebremeskel,&nbsp;Bacha Aberra,&nbsp;Assefa Hika,&nbsp;Yusuf Yimer,&nbsp;Misrak Weldeyohannes,&nbsp;Suleiman Jemal,&nbsp;Degena Behrey,&nbsp;Abere Tilahun","doi":"10.1155/2021/8891252","DOIUrl":"https://doi.org/10.1155/2021/8891252","url":null,"abstract":"<p><strong>Background: </strong>Hypotension and bradycardia are the most common complications associated with spinal anesthesia and more common in patients with a history of hypertension. Regular use of antihypertensive medications can prevent these complications. The occurrence of hypotension under spinal anesthesia among controlled hypertensive and normotensive patients with age 40 years and above is still debated. The objective of the study was to compare blood pressure and heart rate changes following spinal anesthesia between controlled hypertensive and normotensive patients undergoing surgery below the umbilicus at Black lion hospital, Addis Ababa, Ethiopia, 2020.</p><p><strong>Method: </strong>A hospital-based prospective cohort study was conducted. A total of 110 elective patients with controlled hypertension (55) and normotensive (55) patients who underwent surgery with spinal anesthesia at black lion hospital during the study period were included. The sample was selected using a systematic random sampling technique. Continuous data of independent and dependent variables were analyzed using an independent sample <i>t</i>-test for normally distributed and Mann-Whitney <i>U</i>-test for nonnormally distributed between the study groups. Categorical variables between the study groups were analyzed using the chi-square test. Descriptive data were displayed using tables and figures. For continuous and categorical variables, a <i>p</i> value <0.05 was considered statistically significant.</p><p><strong>Results: </strong>The incidence of hypotension in the controlled hypertension group (23.6%) was higher than the normotensive group (7.3%) with <i>p</i> value of 0.018. The occurrence of bradycardia was seen to be 12.7% in each group with a <i>p</i> value >0.05. There was a statistically significant difference in the mean systolic blood pressure, mean arterial pressure, mean heart rate, and vasopressor consumption at the measurement time interval between controlled hypertension and normotensive groups.</p><p><strong>Conclusion: </strong>Under spinal anesthesia, patients with controlled hypertension are more likely to develop hypotension than normotensive patients, but on the occurrence of bradycardia, there was no statistically significant difference between the two groups.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2021 ","pages":"8891252"},"PeriodicalIF":1.4,"publicationDate":"2021-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298159/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39264623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Evidence-Based Guideline on Critical Patient Transport and Handover to ICU. 危重病人转移和转入ICU循证指南。
IF 1.4 Q2 ANESTHESIOLOGY Pub Date : 2021-05-06 eCollection Date: 2021-01-01 DOI: 10.1155/2021/6618709
Tesfaye Belaneh Agizew, Henos Enyew Ashagrie, Habtamu Getinet Kassahun, Mamaru Mollalign Temesgen

The perioperative period is a time in which significant physiological change occurs. Improper transfer of information at this point can lead to medical errors. Planning and preparation for critical patient transport to ICU is vital to prevent adverse events. Critical patient transport to ICU must be as safe as possible and should not cause additional risks. It needs good communication, planning, and appropriate staffing with standard monitoring. Evidence shows inconsistency and variability on the use of standardized protocols during critical patient transfer and handover to the ICU. There is a variety of controversial approaches about the need of sedation, use of end-tidal CO2 monitoring, and manual versus mechanical ventilation based on different evidence. The objective of this review was to recommend safer options of critical patient transfer to the ICU that help reduce patient morbidity and mortality. Methods. Google Scholars, PubMed through HINARI, and other search engines were used to search high-quality evidence that help reach appropriate conclusions. Discussion. Critical patient transfer and handover to ICU is a complex procedure that needs experienced hands, availability of appropriate team members, standard monitoring, and necessary emergency and patient-specific medications. Appropriate and adequate transfer of patient information to the receiving team decreases patient morbidity and mortality when the transfer team uses standardized checklist. Conclusion. Involvement of senior physicians, use of standard monitoring, and appropriate transfer of information have been shown to decrease critical patient morbidity and mortality.

围手术期是发生显著生理变化的时期。此时信息传递不当可能导致医疗差错。计划和准备危重患者转移到ICU是防止不良事件的关键。危重患者转移到ICU必须尽可能安全,不应造成额外的风险。它需要良好的沟通、计划和适当的人员配备以及标准的监控。有证据表明,在危重患者转移和移交至ICU期间,标准化方案的使用存在不一致性和可变性。基于不同的证据,关于是否需要镇静、使用潮末CO2监测以及人工与机械通气存在各种有争议的方法。本综述的目的是推荐危重患者转至ICU的更安全的选择,以帮助降低患者的发病率和死亡率。方法。谷歌学者、PubMed通过HINARI和其他搜索引擎被用来搜索有助于得出适当结论的高质量证据。讨论。重症患者的转移和移交到ICU是一个复杂的过程,需要经验丰富的人员、合适的团队成员、标准的监测以及必要的急诊和患者特异性药物。当转诊团队使用标准化检查表时,适当和充分地将患者信息传递给接诊团队可以降低患者的发病率和死亡率。结论。资深医生的参与、标准监测的使用和适当的信息传递已被证明可以降低危重病人的发病率和死亡率。
{"title":"Evidence-Based Guideline on Critical Patient Transport and Handover to ICU.","authors":"Tesfaye Belaneh Agizew,&nbsp;Henos Enyew Ashagrie,&nbsp;Habtamu Getinet Kassahun,&nbsp;Mamaru Mollalign Temesgen","doi":"10.1155/2021/6618709","DOIUrl":"https://doi.org/10.1155/2021/6618709","url":null,"abstract":"<p><p>The perioperative period is a time in which significant physiological change occurs. Improper transfer of information at this point can lead to medical errors. Planning and preparation for critical patient transport to ICU is vital to prevent adverse events. Critical patient transport to ICU must be as safe as possible and should not cause additional risks. It needs good communication, planning, and appropriate staffing with standard monitoring. Evidence shows inconsistency and variability on the use of standardized protocols during critical patient transfer and handover to the ICU. There is a variety of controversial approaches about the need of sedation, use of end-tidal CO<sub>2</sub> monitoring, and manual versus mechanical ventilation based on different evidence. The objective of this review was to recommend safer options of critical patient transfer to the ICU that help reduce patient morbidity and mortality. <i>Methods</i>. Google Scholars, PubMed through HINARI, and other search engines were used to search high-quality evidence that help reach appropriate conclusions. <i>Discussion</i>. Critical patient transfer and handover to ICU is a complex procedure that needs experienced hands, availability of appropriate team members, standard monitoring, and necessary emergency and patient-specific medications. Appropriate and adequate transfer of patient information to the receiving team decreases patient morbidity and mortality when the transfer team uses standardized checklist. <i>Conclusion</i>. Involvement of senior physicians, use of standard monitoring, and appropriate transfer of information have been shown to decrease critical patient morbidity and mortality.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2021 ","pages":"6618709"},"PeriodicalIF":1.4,"publicationDate":"2021-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118726/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39032168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Incidence, Risk Factors, and Outcomes of Perioperative Atrial Fibrillation following Noncardiothoracic Surgery: A Systematic Review and Meta-Regression Analysis of Observational Studies. 非心胸外科围手术期房颤的发生率、危险因素和结局:观察性研究的系统回顾和meta回归分析
IF 1.4 Q2 ANESTHESIOLOGY Pub Date : 2021-04-28 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5527199
Yamini Subramani, Omar El Tohamy, Daniil Jalali, Mahesh Nagappa, Homer Yang, Ashraf Fayad
<p><strong>Background: </strong>Atrial fibrillation (AF) occurs in 16-30% of patients after cardiac and thoracic surgery and can lead to serious complications like hypoperfusion of vital organs, pulmonary edema, and myocardial infarction. The evidence on risk factors and complications associated with perioperative AF after noncardiothoracic surgery is limited.</p><p><strong>Methods: </strong>The primary objective was to determine demographic and clinical risk factors for new-onset atrial fibrillation associated with noncardiothoracic surgery. A secondary aim was to identify the incidence and odds of perioperative complications associated with the new-onset atrial fibrillation. A systematic search within multiple databases was conducted for studies that explicitly reported on new-onset atrial fibrillation after noncardiothoracic surgery. We reported data on demographics, comorbidities, and perioperative complications as mean difference (MD) or odds ratios (OR) and corresponding 95% confidence interval (CI) using random effects models. A two-sided <i>P</i> value of less than 0.05 was considered significant. We performed meta-regression and sensitivity analysis of various subgroups to confirm the inference of our findings.</p><p><strong>Results: </strong>Eleven studies reporting on 121,517 patients were included, of whom 2,944 developed perioperative AF (incidence rate: 3.7%; 95% CI: 2.3%--6.2%). Advanced age (AF group versus control group: 69.36 ± 10.5 versus 64.37 ± 9.53 years; MD: 4.06; 95% CI: 1.67--6.44; <i>P</i>=0.0009), male gender (52.85% versus 43.59%; OR: 1.08; 95% CI: 0.54 to 1.62; <i>I</i> <sup>2</sup>: 84%; <i>P</i> < 0.0001), preoperative hypertension (60.42% versus 56.51%; OR: 1.15; 95% CI: 1.08 to 1.23; <i>I</i> <sup>2</sup>: 0%; <i>P</i> < 0.00001), diabetes mellitus (22.6% versus 23.04%; OR: 0.97; 95% CI: 0.89 to 1.05; <i>I</i> <sup>2</sup>: 0; <i>P</i> < 0.00001), and cardiac disease (30.64% versus 8.49%; OR: 2.3; 95% CI: 0.28 to 4.31; <i>I</i> <sup>2</sup>: 93%; <i>P</i>=0.03) were found to be significant predictors for perioperative AF. The AF group was at increased odds of developing postoperative cardiac complications (34.1% versus 5%; OR: 5.44; 95% CI: 0.49 to 10.39; <i>I</i> <sup>2</sup>: 82%; <i>P</i>=0.03), postoperative stroke (0.5% versus 0.1%; OR: 3; 95% CI: 0.65 to 5.35; <i>I</i> <sup>2</sup>: 0%; <i>P</i>=0.01), and mortality (7.40% versus 1.92%; OR: 3.58; 95% CI: 0.14 to 7.02; <i>I</i> <sup>2</sup>: 0%; <i>P</i>=0.04). Study quality assessment by meta-regression and sensitivity analysis of the various subgroups did not affect the final inference of the results.</p><p><strong>Conclusion: </strong>We identified advanced age, male gender, preoperative hypertension, diabetes mellitus, and cardiac disease as important risk factors for perioperative atrial fibrillation. The atrial fibrillation group was at increased odds for postoperative cardiac complications, stroke, and higher mortality, emphasizing the need for risk st
背景:16-30%的心脏胸外科术后患者发生心房颤动(AF),可导致重要器官灌注不足、肺水肿和心肌梗死等严重并发症。非心胸外科手术后围手术期房颤相关的危险因素和并发症的证据是有限的。方法:主要目的是确定与非心胸外科手术相关的新发房颤的人口学和临床危险因素。第二个目的是确定与新发心房颤动相关的围手术期并发症的发生率和几率。在多个数据库中进行了系统的搜索,以明确报道非心胸外科手术后新发房颤的研究。我们使用随机效应模型报告了人口统计学、合并症和围手术期并发症的平均差异(MD)或优势比(or)和相应的95%置信区间(CI)。双侧P值小于0.05为显著性。我们对不同亚组进行了meta回归和敏感性分析,以证实我们研究结果的推断。结果:纳入了11项研究,报告了121517例患者,其中2944例发生围手术期房颤(发生率:3.7%;95% ci: 2.3%—6.2%)。高龄(AF组与对照组:69.36±10.5岁∶64.37±9.53岁;MD: 4.06;95% ci: 1.67—6.44;P=0.0009),男性(52.85% vs 43.59%;OR: 1.08;95% CI: 0.54 ~ 1.62;I 2: 84%;P < 0.0001),术前高血压(60.42% vs 56.51%;OR: 1.15;95% CI: 1.08 ~ 1.23;I 2: 0%;P < 0.00001),糖尿病(22.6%比23.04%;OR: 0.97;95% CI: 0.89 ~ 1.05;I 2: 0;P < 0.00001),心脏病(30.64% vs 8.49%;OR: 2.3;95% CI: 0.28 ~ 4.31;I 2: 93%;P=0.03)是围手术期房颤的显著预测因子。房颤组发生术后心脏并发症的几率增加(34.1%比5%;OR: 5.44;95% CI: 0.49 ~ 10.39;I 2: 82%;P=0.03),术后卒中(0.5% vs 0.1%;或者:3;95% CI: 0.65 ~ 5.35;I 2: 0%;P=0.01),死亡率(7.40% vs 1.92%;OR: 3.58;95% CI: 0.14 ~ 7.02;I 2: 0%;P = 0.04)。通过meta回归和各亚组敏感性分析进行的研究质量评估不影响结果的最终推断。结论:高龄、男性、术前高血压、糖尿病和心脏疾病是围手术期房颤的重要危险因素。房颤组术后心脏并发症、卒中和死亡率增加,强调了风险分层和密切监测的必要性。
{"title":"Incidence, Risk Factors, and Outcomes of Perioperative Atrial Fibrillation following Noncardiothoracic Surgery: A Systematic Review and Meta-Regression Analysis of Observational Studies.","authors":"Yamini Subramani,&nbsp;Omar El Tohamy,&nbsp;Daniil Jalali,&nbsp;Mahesh Nagappa,&nbsp;Homer Yang,&nbsp;Ashraf Fayad","doi":"10.1155/2021/5527199","DOIUrl":"https://doi.org/10.1155/2021/5527199","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Atrial fibrillation (AF) occurs in 16-30% of patients after cardiac and thoracic surgery and can lead to serious complications like hypoperfusion of vital organs, pulmonary edema, and myocardial infarction. The evidence on risk factors and complications associated with perioperative AF after noncardiothoracic surgery is limited.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The primary objective was to determine demographic and clinical risk factors for new-onset atrial fibrillation associated with noncardiothoracic surgery. A secondary aim was to identify the incidence and odds of perioperative complications associated with the new-onset atrial fibrillation. A systematic search within multiple databases was conducted for studies that explicitly reported on new-onset atrial fibrillation after noncardiothoracic surgery. We reported data on demographics, comorbidities, and perioperative complications as mean difference (MD) or odds ratios (OR) and corresponding 95% confidence interval (CI) using random effects models. A two-sided &lt;i&gt;P&lt;/i&gt; value of less than 0.05 was considered significant. We performed meta-regression and sensitivity analysis of various subgroups to confirm the inference of our findings.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Eleven studies reporting on 121,517 patients were included, of whom 2,944 developed perioperative AF (incidence rate: 3.7%; 95% CI: 2.3%--6.2%). Advanced age (AF group versus control group: 69.36 ± 10.5 versus 64.37 ± 9.53 years; MD: 4.06; 95% CI: 1.67--6.44; &lt;i&gt;P&lt;/i&gt;=0.0009), male gender (52.85% versus 43.59%; OR: 1.08; 95% CI: 0.54 to 1.62; &lt;i&gt;I&lt;/i&gt; &lt;sup&gt;2&lt;/sup&gt;: 84%; &lt;i&gt;P&lt;/i&gt; &lt; 0.0001), preoperative hypertension (60.42% versus 56.51%; OR: 1.15; 95% CI: 1.08 to 1.23; &lt;i&gt;I&lt;/i&gt; &lt;sup&gt;2&lt;/sup&gt;: 0%; &lt;i&gt;P&lt;/i&gt; &lt; 0.00001), diabetes mellitus (22.6% versus 23.04%; OR: 0.97; 95% CI: 0.89 to 1.05; &lt;i&gt;I&lt;/i&gt; &lt;sup&gt;2&lt;/sup&gt;: 0; &lt;i&gt;P&lt;/i&gt; &lt; 0.00001), and cardiac disease (30.64% versus 8.49%; OR: 2.3; 95% CI: 0.28 to 4.31; &lt;i&gt;I&lt;/i&gt; &lt;sup&gt;2&lt;/sup&gt;: 93%; &lt;i&gt;P&lt;/i&gt;=0.03) were found to be significant predictors for perioperative AF. The AF group was at increased odds of developing postoperative cardiac complications (34.1% versus 5%; OR: 5.44; 95% CI: 0.49 to 10.39; &lt;i&gt;I&lt;/i&gt; &lt;sup&gt;2&lt;/sup&gt;: 82%; &lt;i&gt;P&lt;/i&gt;=0.03), postoperative stroke (0.5% versus 0.1%; OR: 3; 95% CI: 0.65 to 5.35; &lt;i&gt;I&lt;/i&gt; &lt;sup&gt;2&lt;/sup&gt;: 0%; &lt;i&gt;P&lt;/i&gt;=0.01), and mortality (7.40% versus 1.92%; OR: 3.58; 95% CI: 0.14 to 7.02; &lt;i&gt;I&lt;/i&gt; &lt;sup&gt;2&lt;/sup&gt;: 0%; &lt;i&gt;P&lt;/i&gt;=0.04). Study quality assessment by meta-regression and sensitivity analysis of the various subgroups did not affect the final inference of the results.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;We identified advanced age, male gender, preoperative hypertension, diabetes mellitus, and cardiac disease as important risk factors for perioperative atrial fibrillation. The atrial fibrillation group was at increased odds for postoperative cardiac complications, stroke, and higher mortality, emphasizing the need for risk st","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2021 ","pages":"5527199"},"PeriodicalIF":1.4,"publicationDate":"2021-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38997074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Acute Effects of Ketamine Infusion on Postoperative Mood Scores in Patients Undergoing Dilation and Curettage: A Randomized Double-Blind Controlled Study. 氯胺酮输注对刮刮术患者术后情绪评分的急性影响:一项随机双盲对照研究。
IF 1.4 Q2 ANESTHESIOLOGY Pub Date : 2021-03-23 eCollection Date: 2021-01-01 DOI: 10.1155/2021/6674658
Raham Hasan Mostafa, Ahmed Mohamed Khamis, Ashraf Nabil Saleh, Yehia Mamdouh Hassan Mekki, Mohamed Mohamed Kamal, Ismail Mohammed Ibrahim, Mohamed Abdulmohsen Abdulnaiem Ismaiel

Background: Emotional and psychological effects following abortion are more common than physical side effects and can range from mild regret to more serious complications such as depression. In the last decade, it has been suggested that low dose of ketamine is a fast-acting antidepressant.

Purpose: The aim of this study was to investigate the impact of intraoperative ketamine infusion on postoperative mood score in patients undergoing Dilation and Curettage (D&C) under spinal anesthesia. We hypothesized that a single low-dose administration of ketamine infusion during D&C surgery can improve mood scores in the immediate postoperative period.

Methods: A prospective, randomized, double-blind, parallel-group, placebo-controlled trial. The study included a total of 60 patients, ≥18 years, physical status ASA II, with up to 12-week gestation undergoing elective D&C surgery. Patients were divided randomly into a ketamine group (group K) and a control group (group C). In group K, 0.4 mg/kg ketamine was given as a continuous infusion over 20 min intraoperatively. Main Outcome Measure. Profile of Mood States (POMS) was recorded preoperatively and 2 hours postoperatively.

Results: There were no differences in preoperative POMS between the two groups. Mean postoperative POMS of group K was lower than that of group C indicating mood improvement. Ketamine group patients showed higher sedation score and increased, although self-limiting, psychedelic phenomena than the control group.

Conclusion: Observed data here support an acute effect of ketamine on mood but any further claim will be speculative. Further future studies exploring postoperative mood scores after 24 hours post-infusion are needed. This trial is registered with PACTR201907779292947.

背景:流产后的情绪和心理影响比生理副作用更常见,从轻微的后悔到更严重的并发症,如抑郁。在过去的十年里,有人认为低剂量的氯胺酮是一种速效抗抑郁药。目的:本研究旨在探讨术中氯胺酮输注对脊髓麻醉下行扩张刮刮术(D&C)患者术后情绪评分的影响。我们假设在D&C手术中单次低剂量氯胺酮输注可以改善术后即时的情绪评分。方法:前瞻性、随机、双盲、平行组、安慰剂对照试验。本研究共纳入60例患者,年龄≥18岁,身体状态ASA II,妊娠12周,择期行D&C手术。将患者随机分为氯胺酮组(K组)和对照组(C组)。K组术中给予氯胺酮0.4 mg/kg连续输注20 min以上。主要结果测量。术前和术后2小时分别记录心境状态(POMS)。结果:两组术前POMS无明显差异。K组术后平均POMS低于C组,提示情绪改善。氯胺酮组患者镇静评分高于对照组,迷幻现象虽有自限性,但有所增加。结论:这里观察到的数据支持氯胺酮对情绪的急性影响,但任何进一步的说法都将是推测性的。需要进一步研究输注后24小时的术后情绪评分。该试验注册号为PACTR201907779292947。
{"title":"Acute Effects of Ketamine Infusion on Postoperative Mood Scores in Patients Undergoing Dilation and Curettage: A Randomized Double-Blind Controlled Study.","authors":"Raham Hasan Mostafa,&nbsp;Ahmed Mohamed Khamis,&nbsp;Ashraf Nabil Saleh,&nbsp;Yehia Mamdouh Hassan Mekki,&nbsp;Mohamed Mohamed Kamal,&nbsp;Ismail Mohammed Ibrahim,&nbsp;Mohamed Abdulmohsen Abdulnaiem Ismaiel","doi":"10.1155/2021/6674658","DOIUrl":"https://doi.org/10.1155/2021/6674658","url":null,"abstract":"<p><strong>Background: </strong>Emotional and psychological effects following abortion are more common than physical side effects and can range from mild regret to more serious complications such as depression. In the last decade, it has been suggested that low dose of ketamine is a fast-acting antidepressant.</p><p><strong>Purpose: </strong>The aim of this study was to investigate the impact of intraoperative ketamine infusion on postoperative mood score in patients undergoing Dilation and Curettage (D&C) under spinal anesthesia. We hypothesized that a single low-dose administration of ketamine infusion during D&C surgery can improve mood scores in the immediate postoperative period.</p><p><strong>Methods: </strong>A prospective, randomized, double-blind, parallel-group, placebo-controlled trial. The study included a total of 60 patients, ≥18 years, physical status ASA II, with up to 12-week gestation undergoing elective D&C surgery. Patients were divided randomly into a ketamine group (group K) and a control group (group C). In group K, 0.4 mg/kg ketamine was given as a continuous infusion over 20 min intraoperatively. <i>Main Outcome Measure</i>. Profile of Mood States (POMS) was recorded preoperatively and 2 hours postoperatively.</p><p><strong>Results: </strong>There were no differences in preoperative POMS between the two groups. Mean postoperative POMS of group K was lower than that of group C indicating mood improvement. Ketamine group patients showed higher sedation score and increased, although self-limiting, psychedelic phenomena than the control group.</p><p><strong>Conclusion: </strong>Observed data here support an acute effect of ketamine on mood but any further claim will be speculative. Further future studies exploring postoperative mood scores after 24 hours post-infusion are needed. This trial is registered with PACTR201907779292947.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2021 ","pages":"6674658"},"PeriodicalIF":1.4,"publicationDate":"2021-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009713/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38878516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Combined Ventilation of Two Subjects with a Single Mechanical Ventilator Using a New Medical Device: An In Vitro Study. 一种新型医疗器械在单台机械呼吸机下对两名受试者联合通气的体外研究
IF 1.4 Q2 ANESTHESIOLOGY Pub Date : 2021-02-18 eCollection Date: 2021-01-01 DOI: 10.1155/2021/6691591
Ignacio Lugones, Matías Ramos, María Fernanda Biancolini, Roberto Orofino Giambastiani

Introduction: The SARS-CoV-2 pandemic has created a sudden lack of ventilators. DuplicAR is a novel device that allows simultaneous and independent ventilation of two subjects with a single ventilator. The aims of this study are (a) to determine the efficacy of DuplicAR to independently regulate the peak and positive-end expiratory pressures in each subject, both under pressure-controlled ventilation and volume-controlled ventilation and (b) to determine the ventilation mode in which DuplicAR presents the best performance and safety.

Materials and methods: Two test lungs are connected to a single ventilator using DuplicAR. Three experimental stages are established: (1) two identical subjects, (2) two subjects with the same weight but different lung compliance, and (3) two subjects with different weights and lung compliances. In each stage, the test lungs are ventilated in two ventilation modes. The positive-end expiratory pressure requirements are increased successively in one of the subjects. The goal is to achieve a tidal volume of 7 ml/kg for each subject in all different stages through manipulation of the ventilator and the DuplicAR controllers.

Results: DuplicAR allows adequate ventilation of two subjects with different weights and/or lung compliances and/or PEEP requirements. This is achieved by adjusting the total tidal volume for both subjects (in volume-controlled ventilation) or the highest peak pressure needed (in pressure-controlled ventilation) along with the basal positive-end expiratory pressure on the ventilator and simultaneously manipulating the DuplicAR controllers to decrease the tidal volume or the peak pressure in the subject that needs less and/or to increase the positive-end expiratory pressure in the subject that needs more. While ventilatory goals can be achieved in any of the ventilation modes, DuplicAR performs better in pressure-controlled ventilation, as changes experienced in the variables of one subject do not modify the other one.

Conclusions: DuplicAR is an effective tool to manage the peak inspiratory pressure and the positive-end expiratory pressure independently in two subjects connected to a single ventilator. The driving pressure can be adjusted to meet the requirements of subjects with different weights and lung compliances. Pressure-controlled ventilation has advantages over volume-controlled ventilation and is therefore the recommended ventilation mode.

SARS-CoV-2大流行导致呼吸机突然短缺。DuplicARⓇ是一种新颖的设备,可以使用单个呼吸机同时独立地对两名受试者进行通气。本研究的目的是(a)确定DuplicARⓇ在压力控制通气和容积控制通气条件下独立调节每位受试者呼气峰压和呼气正端压的效果;(b)确定DuplicARⓇ表现出最佳性能和安全性的通气模式。材料和方法:使用DuplicARⓇ将两个测试肺连接到单个呼吸机上。建立了三个实验阶段:(1)两个相同的被试,(2)两个体重相同但肺顺应性不同的被试,(3)两个体重不同但肺顺应性不同的被试。在每个阶段,试验肺以两种通气模式通气。其中一名受试者呼气末正压要求依次升高。目标是通过操纵呼吸机和DuplicARⓇ控制器,使每个受试者在所有不同阶段的潮气量达到7 ml/kg。结果:DuplicARⓇ允许两名体重和/或肺顺应性和/或PEEP要求不同的受试者进行充分的通气。这是通过调节两名受试者的总潮气量(在容积控制通气中)或所需的最高峰值压力(在压力控制通气中)以及呼吸机的基本呼气正端压力来实现的,同时操纵DuplicARⓇ控制器来降低需要较少的受试者的潮气量或峰值压力和/或增加需要较多的受试者的呼气正端压力。虽然通风目标可以在任何通风模式下实现,但DuplicARⓇ在压力控制通风中表现更好,因为一个受试者变量的变化不会改变另一个受试者。结论:DuplicARⓇ是一种有效的工具,可以独立管理两名连接一台呼吸机的受试者的峰值吸气压力和呼气正端压力。驱动压力可调节,以满足不同体重和肺顺应性受试者的要求。压力控制通风比容积控制通风有优点,因此是推荐的通风方式。
{"title":"Combined Ventilation of Two Subjects with a Single Mechanical Ventilator Using a New Medical Device: An In Vitro Study.","authors":"Ignacio Lugones,&nbsp;Matías Ramos,&nbsp;María Fernanda Biancolini,&nbsp;Roberto Orofino Giambastiani","doi":"10.1155/2021/6691591","DOIUrl":"https://doi.org/10.1155/2021/6691591","url":null,"abstract":"<p><strong>Introduction: </strong>The SARS-CoV-2 pandemic has created a sudden lack of ventilators. DuplicAR<sup>Ⓡ</sup> is a novel device that allows simultaneous and independent ventilation of two subjects with a single ventilator. The aims of this study are (a) to determine the efficacy of DuplicAR<sup>Ⓡ</sup> to independently regulate the peak and positive-end expiratory pressures in each subject, both under pressure-controlled ventilation and volume-controlled ventilation and (b) to determine the ventilation mode in which DuplicAR<sup>Ⓡ</sup> presents the best performance and safety.</p><p><strong>Materials and methods: </strong>Two test lungs are connected to a single ventilator using DuplicAR<sup>Ⓡ</sup>. Three experimental stages are established: (1) two identical subjects, (2) two subjects with the same weight but different lung compliance, and (3) two subjects with different weights and lung compliances. In each stage, the test lungs are ventilated in two ventilation modes. The positive-end expiratory pressure requirements are increased successively in one of the subjects. The goal is to achieve a tidal volume of 7 ml/kg for each subject in all different stages through manipulation of the ventilator and the DuplicAR<sup>Ⓡ</sup> controllers.</p><p><strong>Results: </strong>DuplicAR<sup>Ⓡ</sup> allows adequate ventilation of two subjects with different weights and/or lung compliances and/or PEEP requirements. This is achieved by adjusting the total tidal volume for both subjects (in volume-controlled ventilation) or the highest peak pressure needed (in pressure-controlled ventilation) along with the basal positive-end expiratory pressure on the ventilator and simultaneously manipulating the DuplicAR<sup>Ⓡ</sup> controllers to decrease the tidal volume or the peak pressure in the subject that needs less and/or to increase the positive-end expiratory pressure in the subject that needs more. While ventilatory goals can be achieved in any of the ventilation modes, DuplicAR<sup>Ⓡ</sup> performs better in pressure-controlled ventilation, as changes experienced in the variables of one subject do not modify the other one.</p><p><strong>Conclusions: </strong>DuplicAR<sup>Ⓡ</sup> is an effective tool to manage the peak inspiratory pressure and the positive-end expiratory pressure independently in two subjects connected to a single ventilator. The driving pressure can be adjusted to meet the requirements of subjects with different weights and lung compliances. Pressure-controlled ventilation has advantages over volume-controlled ventilation and is therefore the recommended ventilation mode.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2021 ","pages":"6691591"},"PeriodicalIF":1.4,"publicationDate":"2021-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896537/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25402407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Perioperative Intravenous Patient-Controlled Analgesic Efficacy of Morphine with Combined Nefopam and Parecoxib versus Parecoxib in Gynecologic Surgery: A Randomized, Double-Blind Study. 妇科手术围手术期静脉注射吗啡联合奈福泮和帕瑞考西与帕瑞考西的自控镇痛效果:一项随机双盲研究。
IF 1.4 Q2 ANESTHESIOLOGY Pub Date : 2021-02-12 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5461890
Varinee Lekprasert, Lapuskorn Yapanan, Wichai Ittichaikulthol, Rungrawan Buachai, Phimol Soisod, Areepan Sophonsritsuk

Background: Nefopam is a non-NSAIDs and opioid sparing centrally acting drug which is effective for a multimodal postoperative analgesia. The present study aimed to evaluate the analgesic efficacy of nefopam combined with parecoxib for gynecologic surgery.

Methods: This randomized double-blinded control trial recruited participants (n = 72) who underwent gynecologic surgeries and divided them into either a nefopam or control group. The study group received parecoxib 40 mg plus nefopam 20 mg, while the control group received parecoxib 40 mg plus normal saline solution intravenously during open abdominal gynecological surgery. Both groups then received either nefopam or normal saline every 6 hours postoperatively for 24 hours. Intravenous patient-controlled analgesia with morphine was given for breakthrough pain within 24 h. The participants were evaluated for morphine consumption within 24 hours and postoperative pain using a verbal numerical rating scale (VNRS) at a postanesthetic care unit, at 6-, 12-, and 24-hour postoperative periods. Adverse effects were recorded.

Results: Morphine consumption within 24 hours and adverse effects were not significantly different between both groups. Mean difference and 95% confident interval of morphine consumption between both groups was 1.00 (-4.56, 4.76), P=0.97. The VNRS on movement at 6 hours after surgery of the nefopam group was significantly different from that of the control group [mean (SD), 4.14 (2.11) vs. 5.14 (1.80), P=0.04]. The VNRS of the nefopam group at 12 hours after operation during resting and on movement was significantly different from that of the control group ([mean (SD), 1.47 (1.80) vs. 2.54 (2.15), P=0.03], [mean (SD), 3.22 (1.84) vs 4.17 (1.74), P=0.03]), respectively.

Conclusions: The combined administration of nefopam and parecoxib during gynecologic surgery slightly reduced the VNRS at 6 and 12 hours postoperatively more than treatment with parecoxib.

背景:奈福泮是一种非非甾体抗炎药和阿片类药物保留中枢作用药物,可用于多模式术后镇痛。本研究旨在评价奈福泮联合帕瑞昔布用于妇科手术的镇痛效果。方法:这项随机双盲对照试验招募了72名接受妇科手术的患者,并将其分为尼福泮组和对照组。研究组在妇科开腹手术中静脉给予帕瑞昔布40 mg +尼福泮20 mg,对照组给予帕瑞昔布40 mg +生理盐水。两组术后每隔6小时给予尼福泮或生理盐水治疗,持续24小时。突破性疼痛在24 h内给予吗啡静脉自控镇痛。在术后护理单元,分别于术后6、12和24小时使用口头数字评定量表(VNRS)评估参与者24小时内吗啡用量和术后疼痛。记录不良反应。结果:两组患者24h内吗啡用量及不良反应无显著性差异。两组吗啡用量的平均差异和95%可信区间为1.00 (-4.56,4.76),P=0.97。nefopam组术后6 h运动VNRS与对照组比较差异有统计学意义[mean (SD), 4.14 (2.11) vs. 5.14 (1.80), P=0.04]。nefopam组术后12 h静息和运动时VNRS与对照组比较差异有统计学意义([mean (SD), 1.47 (1.80) vs 2.54 (2.15), P=0.03], [mean (SD), 3.22 (1.84) vs 4.17 (1.74), P=0.03])。结论:妇科手术中联合应用奈福帕泮和帕瑞昔布比单用帕瑞昔布更能降低术后6和12小时的VNRS。
{"title":"Perioperative Intravenous Patient-Controlled Analgesic Efficacy of Morphine with Combined Nefopam and Parecoxib versus Parecoxib in Gynecologic Surgery: A Randomized, Double-Blind Study.","authors":"Varinee Lekprasert,&nbsp;Lapuskorn Yapanan,&nbsp;Wichai Ittichaikulthol,&nbsp;Rungrawan Buachai,&nbsp;Phimol Soisod,&nbsp;Areepan Sophonsritsuk","doi":"10.1155/2021/5461890","DOIUrl":"https://doi.org/10.1155/2021/5461890","url":null,"abstract":"<p><strong>Background: </strong>Nefopam is a non-NSAIDs and opioid sparing centrally acting drug which is effective for a multimodal postoperative analgesia. The present study aimed to evaluate the analgesic efficacy of nefopam combined with parecoxib for gynecologic surgery.</p><p><strong>Methods: </strong>This randomized double-blinded control trial recruited participants (<i>n</i> = 72) who underwent gynecologic surgeries and divided them into either a nefopam or control group. The study group received parecoxib 40 mg plus nefopam 20 mg, while the control group received parecoxib 40 mg plus normal saline solution intravenously during open abdominal gynecological surgery. Both groups then received either nefopam or normal saline every 6 hours postoperatively for 24 hours. Intravenous patient-controlled analgesia with morphine was given for breakthrough pain within 24 h. The participants were evaluated for morphine consumption within 24 hours and postoperative pain using a verbal numerical rating scale (VNRS) at a postanesthetic care unit, at 6-, 12-, and 24-hour postoperative periods. Adverse effects were recorded.</p><p><strong>Results: </strong>Morphine consumption within 24 hours and adverse effects were not significantly different between both groups. Mean difference and 95% confident interval of morphine consumption between both groups was 1.00 (-4.56, 4.76), <i>P</i>=0.97. The VNRS on movement at 6 hours after surgery of the nefopam group was significantly different from that of the control group [mean (SD), 4.14 (2.11) vs. 5.14 (1.80), <i>P</i>=0.04]. The VNRS of the nefopam group at 12 hours after operation during resting and on movement was significantly different from that of the control group ([mean (SD), 1.47 (1.80) vs. 2.54 (2.15), <i>P</i>=0.03], [mean (SD), 3.22 (1.84) vs 4.17 (1.74), <i>P</i>=0.03]), respectively.</p><p><strong>Conclusions: </strong>The combined administration of nefopam and parecoxib during gynecologic surgery slightly reduced the VNRS at 6 and 12 hours postoperatively more than treatment with parecoxib.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2021 ","pages":"5461890"},"PeriodicalIF":1.4,"publicationDate":"2021-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895606/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25402406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Smooth Extubation and Smooth Emergence Techniques: A Narrative Review. 顺畅拔管与顺畅出管技术:叙述性回顾。
IF 1.4 Q2 ANESTHESIOLOGY Pub Date : 2021-01-15 eCollection Date: 2021-01-01 DOI: 10.1155/2021/8883257
Tiffany H Wong, Garret Weber, Apolonia E Abramowicz

There is a paucity of literature on extubation technique and a lack of consensus regarding the definition of smooth extubation. This narrative review paper defines an ideal extubation, otherwise known as a "smooth extubation," reviews perioperative criteria for extubation and risks and adverse events related to extubation, and explores various perioperative techniques that can be used to achieve a smooth extubation while caring for an uncomplicated patient without significant risk factors for extubation failure. In light of the evolving practice during the SARS CoV2 (COVID-19) pandemic to minimize aerosol generation and infection transmission, smooth extubation is particularly important.

关于拔管技术的文献很少,对于顺利拔管的定义也缺乏共识。这篇叙述性综述文章定义了理想的拔管,也被称为“顺利拔管”,回顾了拔管的围手术期标准以及与拔管相关的风险和不良事件,并探讨了各种围手术期技术,这些技术可用于在照顾无明显拔管失败风险因素的简单患者时实现顺利拔管。鉴于在SARS - CoV2 (COVID-19)大流行期间不断发展的减少气溶胶产生和感染传播的做法,顺利拔管尤为重要。
{"title":"Smooth Extubation and Smooth Emergence Techniques: A Narrative Review.","authors":"Tiffany H Wong,&nbsp;Garret Weber,&nbsp;Apolonia E Abramowicz","doi":"10.1155/2021/8883257","DOIUrl":"https://doi.org/10.1155/2021/8883257","url":null,"abstract":"<p><p>There is a paucity of literature on extubation technique and a lack of consensus regarding the definition of smooth extubation. This narrative review paper defines an ideal extubation, otherwise known as a \"smooth extubation,\" reviews perioperative criteria for extubation and risks and adverse events related to extubation, and explores various perioperative techniques that can be used to achieve a smooth extubation while caring for an uncomplicated patient without significant risk factors for extubation failure. In light of the evolving practice during the SARS CoV2 (COVID-19) pandemic to minimize aerosol generation and infection transmission, smooth extubation is particularly important.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2021 ","pages":"8883257"},"PeriodicalIF":1.4,"publicationDate":"2021-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822686/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38873036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
A New Medical Device to Provide Independent Ventilation to Two Subjects Using a Single Ventilator: Evaluation in Lung-Healthy Pigs. 一种使用单一呼吸机为两个受试者提供独立通气的新型医疗设备:肺健康猪的评估。
IF 1.4 Q2 ANESTHESIOLOGY Pub Date : 2020-12-30 eCollection Date: 2020-01-01 DOI: 10.1155/2020/8866806
Ignacio Lugones, Roberto Orofino Giambastiani, Oscar Robledo, Martín Marcos, Javier Mouly, Agustín Gallo, Verónica Laulhé, María Fernanda Biancolini

Background: The global crisis situation caused by SARS-CoV-2 has created an explosive demand for ventilators, which cannot be met even in developed countries. Designing a simple and inexpensive device with the ability to increase the number of patients that can be connected to existing ventilators would have a major impact on the number of lives that could be saved. We conducted a study to determine whether two pigs with significant differences in size and weight could be ventilated simultaneously using a single ventilator connected to a new medical device called DuplicARⓇ.

Methods: Six pigs (median weight 12 kg, range 9-25 kg) were connected in pairs to a single ventilator using the new device for 6 hours. Both the ventilator and the device were manipulated throughout the experiment according to the needs of each animal. Tidal volume and positive end-expiratory pressure were individually controlled with the device. Primary and secondary outcome variables were defined to assess ventilation and hemodynamics in all animals throughout the experiment.

Results: Median difference in weight between the animals of each pair was 67% (range: 11-108). All animals could be successfully oxygenated and ventilated for 6 hours through manipulation of the ventilator and the DuplicARⓇ device, despite significant discrepancies in body size and weight. Mean PaCO2 in arterial blood was 42.1 ± 4.4 mmHg, mean PaO2 was 162.8 ± 46.8 mmHg, and mean oxygen saturation was 98 ± 1.3%. End-tidal CO2 values showed no statistically significant difference among subjects of each pair. Mean difference in arterial PaCO2 measured at the same time in both animals of each pair was 4.8 ± 3 mmHg, reflecting the ability of the device to ventilate each animal according to its particular requirements. Independent management of PEEP was achieved by manipulation of the device controllers.

Conclusion: It is possible to ventilate two lung-healthy animals with a single ventilator according to each one's needs through manipulation of both the ventilator and the DuplicARⓇ device. This gives this device the potential to expand local ventilators surge capacity during disasters or pandemics until emergency supplies can be delivered from central stockpiles.

背景:新型冠状病毒肺炎(SARS-CoV-2)引发的全球危机局势,导致对呼吸机的需求激增,即使在发达国家也无法满足。设计一种简单而廉价的设备,能够增加可以连接到现有呼吸机的患者数量,这将对可以挽救的生命数量产生重大影响。我们进行了一项研究,以确定是否可以使用连接到名为DuplicARⓇ的新型医疗设备的单个呼吸机同时对两只大小和体重有显著差异的猪进行通气。方法:6头猪(中位体重12 kg,范围9-25 kg)成对使用新装置连接单台呼吸机6小时。在整个实验过程中,根据每只动物的需要对呼吸机和装置进行操作。潮汐量和呼气末正压分别由该装置控制。定义了主要和次要结局变量,以评估整个实验过程中所有动物的通气和血流动力学。结果:每对动物的体重中位数差为67%(范围:11-108)。所有动物都可以通过操作呼吸机和DuplicARⓇ装置成功充氧和通气6小时,尽管体型和体重存在显着差异。动脉血PaCO2平均值为42.1±4.4 mmHg, PaO2平均值为162.8±46.8 mmHg,血氧饱和度平均值为98±1.3%。潮末CO2值在两组被试间差异无统计学意义。每对动物同时测得的动脉血PaCO2平均差值为4.8±3 mmHg,反映了设备对每只动物按其特定要求通气的能力。通过对设备控制器的操作,实现了PEEP的独立管理。结论:通过同时操作呼吸机和DuplicARⓇ装置,可以实现两台肺健康动物按需单台呼吸机通气。这使得该设备有可能在灾害或流行病期间扩大当地呼吸机的激增能力,直到紧急物资可以从中央库存中交付。
{"title":"A New Medical Device to Provide Independent Ventilation to Two Subjects Using a Single Ventilator: Evaluation in Lung-Healthy Pigs.","authors":"Ignacio Lugones,&nbsp;Roberto Orofino Giambastiani,&nbsp;Oscar Robledo,&nbsp;Martín Marcos,&nbsp;Javier Mouly,&nbsp;Agustín Gallo,&nbsp;Verónica Laulhé,&nbsp;María Fernanda Biancolini","doi":"10.1155/2020/8866806","DOIUrl":"https://doi.org/10.1155/2020/8866806","url":null,"abstract":"<p><strong>Background: </strong>The global crisis situation caused by SARS-CoV-2 has created an explosive demand for ventilators, which cannot be met even in developed countries. Designing a simple and inexpensive device with the ability to increase the number of patients that can be connected to existing ventilators would have a major impact on the number of lives that could be saved. We conducted a study to determine whether two pigs with significant differences in size and weight could be ventilated simultaneously using a single ventilator connected to a new medical device called DuplicARⓇ.</p><p><strong>Methods: </strong>Six pigs (median weight 12 kg, range 9-25 kg) were connected in pairs to a single ventilator using the new device for 6 hours. Both the ventilator and the device were manipulated throughout the experiment according to the needs of each animal. Tidal volume and positive end-expiratory pressure were individually controlled with the device. Primary and secondary outcome variables were defined to assess ventilation and hemodynamics in all animals throughout the experiment.</p><p><strong>Results: </strong>Median difference in weight between the animals of each pair was 67% (range: 11-108). All animals could be successfully oxygenated and ventilated for 6 hours through manipulation of the ventilator and the DuplicARⓇ device, despite significant discrepancies in body size and weight. Mean PaCO<sub>2</sub> in arterial blood was 42.1 ± 4.4 mmHg, mean PaO<sub>2</sub> was 162.8 ± 46.8 mmHg, and mean oxygen saturation was 98 ± 1.3%. End-tidal CO<sub>2</sub> values showed no statistically significant difference among subjects of each pair. Mean difference in arterial PaCO<sub>2</sub> measured at the same time in both animals of each pair was 4.8 ± 3 mmHg, reflecting the ability of the device to ventilate each animal according to its particular requirements. Independent management of PEEP was achieved by manipulation of the device controllers.</p><p><strong>Conclusion: </strong>It is possible to ventilate two lung-healthy animals with a single ventilator according to each one's needs through manipulation of both the ventilator and the DuplicARⓇ device. This gives this device the potential to expand local ventilators surge capacity during disasters or pandemics until emergency supplies can be delivered from central stockpiles.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2020 ","pages":"8866806"},"PeriodicalIF":1.4,"publicationDate":"2020-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774300/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38831361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The Role of Interfascial Plane Blocks in Paediatric Regional Anaesthesia: A Narrative Review of Current Perspectives and Updates. 筋膜间平面阻滞在儿科区域麻醉中的作用:当前观点和更新的叙述回顾。
IF 1.4 Q2 ANESTHESIOLOGY Pub Date : 2020-12-19 eCollection Date: 2020-01-01 DOI: 10.1155/2020/8892537
Sujana Dontukurthy, Roshanak Mofidi

Regional anaesthesia has been increasingly used for analgesia in the perioperative period in paediatric anaesthesia for better pain control and improved patient outcomes. Interfascial plane blocks are considered as a subgroup of peripheral nerve blocks. The advent of ultrasound in modern regional anaesthesia practice has led to the evolution of various interfascial plane blocks. The ease of their performance and the low complication rates, compared with neuraxial anaesthesia, have led to their increased use in the perioperative period. Interfascial plane blocks are often incorporated in the multimodal analgesia regimen in the early recovery and ambulation after surgery protocols for various chest wall and abdominal surgeries. This achieves better pain control and decreases the requirements of opioids in the perioperative period, thereby facilitating early mobilization and discharge. This narrative review focuses on the relevant anatomic considerations, technique for the performance of each block along with its current applications and limitations, and includes a review of the current literature on various interfascial plane blocks in paediatric regional anaesthesia.

区域麻醉越来越多地用于围手术期的儿科麻醉镇痛,以更好地控制疼痛和改善患者预后。筋膜间平面阻滞被认为是周围神经阻滞的一个亚群。超声在现代区域麻醉实践中的出现导致了各种筋膜间面阻滞的发展。与轴向麻醉相比,其操作简便,并发症发生率低,因此在围手术期的应用越来越多。在各种胸壁和腹部手术后的早期恢复和走动方案中,筋膜间平面阻滞常被纳入多模式镇痛方案。这样可以更好地控制疼痛,减少围手术期对阿片类药物的需求,从而促进早期动员和出院。这篇叙述性综述的重点是相关的解剖学考虑,每个阻滞的技术及其当前的应用和局限性,并包括目前关于儿科区域麻醉中各种筋膜平面阻滞的文献综述。
{"title":"The Role of Interfascial Plane Blocks in Paediatric Regional Anaesthesia: A Narrative Review of Current Perspectives and Updates.","authors":"Sujana Dontukurthy,&nbsp;Roshanak Mofidi","doi":"10.1155/2020/8892537","DOIUrl":"https://doi.org/10.1155/2020/8892537","url":null,"abstract":"<p><p>Regional anaesthesia has been increasingly used for analgesia in the perioperative period in paediatric anaesthesia for better pain control and improved patient outcomes. Interfascial plane blocks are considered as a subgroup of peripheral nerve blocks. The advent of ultrasound in modern regional anaesthesia practice has led to the evolution of various interfascial plane blocks. The ease of their performance and the low complication rates, compared with neuraxial anaesthesia, have led to their increased use in the perioperative period. Interfascial plane blocks are often incorporated in the multimodal analgesia regimen in the early recovery and ambulation after surgery protocols for various chest wall and abdominal surgeries. This achieves better pain control and decreases the requirements of opioids in the perioperative period, thereby facilitating early mobilization and discharge. This narrative review focuses on the relevant anatomic considerations, technique for the performance of each block along with its current applications and limitations, and includes a review of the current literature on various interfascial plane blocks in paediatric regional anaesthesia.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2020 ","pages":"8892537"},"PeriodicalIF":1.4,"publicationDate":"2020-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765726/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38767655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
期刊
Anesthesiology Research and Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1